ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry

• Anne-Laure Renault,

  Affiliation Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• Fabienne Lesueur,

  Affiliation INSERM, U900, Mines ParisTech, Institut Curie, Paris, France

  ⨯
• Yan Coulombe,

  Affiliation Genome Stability Laboratory, Centre Hospitalier Universitaire de Québec Research Center, HDQ Pavillon, Oncology Axis, Quebec, Canada

  ⨯
• Stéphane Gobeil,

  Affiliation Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• Penny Soucy,

  Affiliation Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• Yosr Hamdi,

  Affiliation Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• Sylvie Desjardins,

  Affiliation Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• Florence Le Calvez-Kelm,

  Affiliation Genetic Cancer Susceptibility group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Maxime Vallée,

  Affiliations Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada, Genetic Cancer Susceptibility group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Catherine Voegele,

  Affiliation Genetic Cancer Susceptibility group, International Agency for Research on Cancer, Lyon, France

  ⨯
• The Breast Cancer Family Registry ,

  ¶Complete membership of the BCFR can be found in the Acknowledgments.

  Affiliations Center for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada, Department of Molecular Genetics, University of Toronto, Toronto, Canada, Genetic Epidemiology Laboratory, The University of Melbourne, Victoria, Australia, Cancer Prevention Institute of California, Fremont, United States of America, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, United States of America

  ⨯
• John L. Hopper,

  Affiliation Center for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia

  ⨯
• Irene L. Andrulis,

  Affiliations Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada, Department of Molecular Genetics, University of Toronto, Toronto, Canada

  ⨯
• Melissa C. Southey,

  Affiliation Genetic Epidemiology Laboratory, The University of Melbourne, Victoria, Australia

  ⨯
• Esther M. John,

  Affiliations Cancer Prevention Institute of California, Fremont, United States of America, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, United States of America

  ⨯
• Jean-Yves Masson,

  Affiliations Genome Stability Laboratory, Centre Hospitalier Universitaire de Québec Research Center, HDQ Pavillon, Oncology Axis, Quebec, Canada, Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University, Quebec, Canada

  ⨯
• Sean V. Tavtigian,

  Affiliations Department of Oncological Sciences, University of Utah, Salt Lake City, United States of America, Huntsman Cancer Institute, University of Utah, Salt Lake City, United States of America

  ⨯
•  [ ... ],
• Jacques Simard

  * E-mail: Jacques.Simard@crchudequebec.ulaval.ca

  Affiliation Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• [ view all ]
• [ view less ]